Benjamin Forbes
Impact in
- Biological Psychiatry top 5%
- Clinical Psychology top 2%
- Psychedelics and Drug Studies
Papers in
-
- Inhalation and Respiratory Drug Delivery 4
- Cystic Fibrosis Research Advances 3
- Tracheal and airway disorders 3
-
- Gut microbiota and health 2
- Co-authors
- Stephen Pilling (1 shared paper)Robin Carhart‐Harris (1 shared paper)David Erritzøe (1 shared paper)Mark Bolstridge (1 shared paper)Michael Bloomfield (1 shared paper)David Taylor (1 shared paper)Camilla Day (1 shared paper)Mendel Kaelen (1 shared paper)
- Journals
- European Journal of Pharmaceutics and Biopharmaceutics (3 papers)American Journal of Respiratory and Critical Care Medicine (1 paper)The Clinical Neuropsychologist (1 paper)Frontiers in Immunology (1 paper)Journal of Cystic Fibrosis (1 paper)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Benjamin Forbes
13 papers receiving 1.4k citations
Benjamin Forbes's Hit Papers
Peers
Comparison fields: 5 of 111
- Biological Psychiatry 78
- Clinical Psychology 614
- Cellular and Molecular Neuroscience 316
- Organic Chemistry 417
- Pharmaceutical Science 75
Countries citing papers authored by Benjamin Forbes
This map shows the geographic impact of Benjamin Forbes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Forbes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Forbes more than expected).
Fields of papers citing papers by Benjamin Forbes
This network shows the impact of papers produced by Benjamin Forbes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Forbes. The network helps show where Benjamin Forbes may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin Forbes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Psilocybin with psychological support for treatment-resistant depression: six-month follow-up Hit paper breakdown → | 2017 | 646 |
| 2 | 2011 | 191 | |
| 3 | 2012 | 117 | |
| 4 | 2011 | 102 | |
| 5 | 2015 | 82 | |
| 6 | 2015 | 81 | |
| 7 | 2008 | 72 | |
| 8 | 2010 | 51 | |
| 9 | 2009 | 31 | |
| 10 | 2013 | 29 | |
| 11 | 2019 | 10 | |
| 12 | 1994 | 3 | |
| 13 | 2025 | 1 |
About Benjamin Forbes
Benjamin Forbes is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Infectious Diseases, Surgery and Clinical Psychology, having authored 13 papers that have together received 1.4k indexed citations. Recurring topics across this work include Inhalation and Respiratory Drug Delivery (4 papers), Cystic Fibrosis Research Advances (3 papers), Tracheal and airway disorders (3 papers), Gut microbiota and health (2 papers), Tuberculosis Research and Epidemiology (2 papers), Nanoparticle-Based Drug Delivery (2 papers), Infectious Diseases and Tuberculosis (2 papers) and Mycobacterium research and diagnosis (2 papers). The work is most often cited by research in Biological Psychiatry (78 citations), Clinical Psychology (614 citations), Cellular and Molecular Neuroscience (316 citations), Organic Chemistry (417 citations) and Pharmaceutical Science (75 citations). Benjamin Forbes has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Stephen Pilling, Robin Carhart‐Harris, David Erritzøe, Mark Bolstridge, Michael Bloomfield, David Taylor, Camilla Day, Mendel Kaelen, Valerie H. Curran and Amanda Feilding. Their work appears in journals such as European Journal of Pharmaceutics and Biopharmaceutics, American Journal of Respiratory and Critical Care Medicine, The Clinical Neuropsychologist, Frontiers in Immunology and Journal of Cystic Fibrosis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.